Results for FAQs (69)

A biosimilar is a biologic that comes to market after the originator drug. A “biosimilar” is a Health Canada-approved medicine that has the same positive health outcomes for patients as the originator

The maintenance medication policy requires pharmacists to dispense at least a 90-day supply for several maintenance drugs. Maintenance drugs are used to control and manage a variety of chronic or long

This highly effective program helps plan members currently taking one of the impacted originator biologic drugs to transition to the corresponding biosimilar product. This program applies in all

To check if you are eligible, select the “Am I Covered” option in the left menu and follow the steps to check eligibility. Continue reading below for more information. If a TENS machine is included in